First Blog Post In Series Examines History Of Artemisinin Development
Council on Foreign Relations’ “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part I
Yanzhong Huang, CFR senior fellow for global health, examines the history of artemisinin drug development in China during the Cold War era. “…It would take another two decades before [artemisinin-combination therapies (ACTs)] were officially adopted by the World Health Organization (WHO) as frontline drugs in the global fight against malaria. Paradoxically, even today artemisinin-based drugs made in China only accounts for one percent of the international market share. Why? This will be the subject of my next blog post” (2/27).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.